A Study of the Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Center Reference Endotoxin in Normal Volunteers.

Trial Profile

A Study of the Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Center Reference Endotoxin in Normal Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Anakinra (Primary)
  • Indications Cryopyrin-associated periodic syndromes; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacodynamics
  • Acronyms Kintox
  • Most Recent Events

    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Oct 2011 Actual initiation date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 04 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top